Protective action of a calcium antagonist, nilvadipine, against aortic calcium deposition — a pathogenic factor in atherosclerosis
- 30 September 1988
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 73 (2-3) , 181-189
- https://doi.org/10.1016/0021-9150(88)90040-8
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Antiatherogenic activity of FR34235 (Nilvadipine), a new potent calcium antagonistAtherosclerosis, 1987
- Smooth muscle cell proliferation in the rat coronary artery induced by vitamin DAtherosclerosis, 1987
- Protection by verapamil of globally ischemic rat hearts: Energy preservation, a partial explanationJournal of Molecular and Cellular Cardiology, 1985
- Effects of Diltiazem on Extent of Ultimate Myocardial Injury Resulting from Temporary Coronary Artery Occlusion in DogsJournal of Cardiovascular Pharmacology, 1982
- The role of calcium in cell deathLife Sciences, 1981
- Calcium Dependence of Toxic Cell Death: A Final Common PathwayScience, 1979
- Pharmacological protection of mitochondrial function in hypoxic heart muscle: Effect of verapamil, propranolol, and methylprednisoloneCardiovascular Research, 1978
- Response of Intestinal Calcium Transport and Bone Calcium Mobilization to 1,25-Dihydroxyvitamin Da in Thyroparathyroidectomized Rats1Endocrinology, 1974
- Atherosclerosis and the Arterial Smooth Muscle CellScience, 1973
- Early Stages of in vitro Calcification of Human Aortic TissueNature, 1969